Opioid use disorder (OUD) remains a pervasive and devastating public health challenge in the United States. Alaska Native and American Indian (ANAI) communities continue to experience a disproportionate share of the burden, with persistent disparities in access to care, treatment retention, and overdose mortality. Historical trauma, systemic inequities, and limited availability of culturally appropriate services contribute significantly to these outcomes.

A recently published article in the Journal of Addiction Medicine, titled “Buprenorphine/Naloxone Treatment Retention and Predictors Among American Indian and Alaska Native Individuals with Opioid Use Disorder”, offers timely and essential insight into this issue. The study, conducted through the Southcentral Foundation in Anchorage, Alaska, examined the treatment retention outcomes for 240 ANAI adults who initiated buprenorphine/naloxone between 2015 and 2019. Researchers observed that retention rates were 63% at 90 days, 51% at 6 months, and 40% at one year. These retention rates, while not far below national averages, reveal opportunities for intervention, especially considering the distinct contextual factors facing ANAI individuals.

The study identified two major predictors of lower retention: younger age and co-occurring substance use. These findings align with broader clinical trends but hold unique implications for this population. Younger patients were more likely to discontinue treatment early, suggesting that programs should consider developmentally tailored interventions. Peer mentorship, youth-focused recovery curricula, and integration with community and educational institutions may help reduce attrition among younger adults.

Equally important is the challenge of poly-substance use. Many patients entering treatment for OUD may also struggle with alcohol, methamphetamine, or benzodiazepine use. This complexity necessitates comprehensive, integrated models of care that do not treat opioid dependence in isolation. Treating these co-occurring dependencies as part of a unified recovery plan—ideally with trauma-informed and culturally safe methodologies—is more likely to yield durable outcomes.

The cultural context surrounding addiction and recovery in ANAI communities cannot be overlooked. The study authors rightly point out the importance of incorporating culturally relevant elements into treatment programming. This includes engaging community elders, integrating traditional healing practices, and ensuring that care is respectful of cultural norms and values. Healing, in many Indigenous traditions, involves restoring balance not only to the individual but also to families and communities. When treatment centers take this broader spiritual and social view, they are more likely to foster trust and long-term engagement.

This discussion is especially urgent when viewed against the backdrop of broader epidemiological data. According to a CDC study, drug overdose death rates among American Indians and Alaska Natives were 2.7 times higher than those of White Americans between 2013 and 2015. Moreover, racial misclassification on death certificates leads to significant underreporting of mortality among ANAI people—by an estimated 40%—masking the true scale of the crisis.

References:

1. Dickerson, D. L., Baldwin, J. A., Belcourt, A., et al. (2021). Buprenorphine/Naloxone Treatment Retention and Predictors Among American Indian and Alaska Native Individuals With Opioid Use Disorder. Journal of Addiction Medicine, 15(4), 297–305.
   Available at: https://journals.lww.com/journaladdictionmedicine/fulltext/2021/08000/buprenorphine_naloxone_treatment_retention_and.9.aspx

2. O’Donnell, J., Gladden, R. M., Mattson, C. L., et al. (2018). Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015. MMWR Morb Mortal Wkly Rep; 67(50): 1373–1377.
   Available at: https://www.cdc.gov/mmwr/volumes/67/wr/mm6750a2.htm

3. Herne, M. A., Bartholomew, M. L., & Weahkee, R. (2014). Suicide Mortality Among American Indians and Alaska Natives, 1999–2009. American Journal of Public Health, 104(S3), S336–S342.
   Available at: https://ajph.aphapublications.org/doi/10.2105/AJPH.2014.301929

4. Substance Abuse and Mental Health Services Administration (SAMHSA). (2020). The Opioid Crisis and the Tribal Communities.
   Available at: https://www.samhsa.gov/sites/default/files/topics/tribal-affairs/opioids-tribal-factsheet.pdf

Call to Action:

The Alaska Society of Addiction Medicine encourages healthcare providers, policymakers, and community leaders to consider the practical implications of these findings. Treatment programs serving ANAI populations should:

— Develop youth-specific support tracks that include mentorship, community connection, and culturally resonant counseling.
— Integrate care for co-occurring substance use disorders within the same treatment setting to reflect the real-world needs of patients.
— Actively incorporate traditional knowledge, spiritual wellness, and Indigenous healing frameworks in clinical protocols.
— Collaborate with tribal health organizations to co-design treatment plans that center the patient within their family, tribe, and cultural ecosystem.